Antipsychotics

Filter By
This session will address several hidden dangers of dementia in the nursing home setting including smoking, dysphagia, and use of antipsychotic medications. We will discuss available assessment tools and risk stratification methods, which are...
This session will address a wide range of issues of interest to practitioners caring for residents in the assisted living setting. Two recent CMS Innovation Grant projects, including one about the use of INTERACT in AL, will be presented. Clinical...
This session will present a case-based approach to enable discussion of various psychiatric syndromes, diagnosis, and treatment options using different classes of psychopharmacological agents. Presenters will discuss indication side effects drug...
This program will outline the requirements and describe the integration of Medication Therapy Management (MTM) services into care planning of long-term care residents. Through collaboration, pharmacists, nurses, and physicians can improve care for...
This session will address the legal risks associated with antipsychotics. The applicable federal regulations and CMS' recent initiatives will be explored on a practical level. Among the presentation methods will be actual cases where nursing...
This program will present the tools necessary for implementing a successful antipsychotic reduction program. Non-pharmacological interventions are the mainstay of therapy, and a strategy of staff and family education, along with a willingness to try...
June 17, 2015
The studies that led to warnings from health regulators against prescribing antipsychotics to elderly patients with dementia were biased, and there is actually no significant increase in risk of death linked to the drugs, according to a study in...
August 13, 2015
The $3.83B company on August 6, 2015 announced the publication of new data from its ongoing open-label safety extension study, the -015 Study, with NUPLAZID™ in patients with Parkinson’s disease psychosis (PDP) in the July 31 online issue of the...
October 7, 2015
Published in the October 1, 2015 issue of the Journal of the American Medical Directors Association , the study found that participants (age 30 to 80 years with an established diagnosis of idiopathic Parkinson’s disease and moderate to severe...
Resolution and Position Statements
Policy E12 THEREFORE BE IT RESOLVED, that AMDA – Dedicated to Long Term Care Medicine collaborate with the Centers for Medicare & Medicaid Services to create educational tools and programs to promote the broad and appropriate implementation of...